Assessing the Transmissibility of the New SARS-CoV-2 Variants: From Delta to Omicron

被引:14
|
作者
Dong, Rui [1 ,2 ]
Hu, Taojun [3 ]
Zhang, Yunjun [3 ]
Li, Yang [4 ]
Zhou, Xiao-Hua [3 ,5 ]
机构
[1] Tsinghua Univ, Yau Math Sci Ctr, Beijing 100084, Peoples R China
[2] Yanqi Lake Beijing Inst Math Sci & Applicat, Beijing 101408, Peoples R China
[3] Peking Univ, Sch Publ Hlth, Dept Biostat, Beijing 100191, Peoples R China
[4] Univ Chinese Acad Sci, Chongqing Sch, Chongqing 400020, Peoples R China
[5] Peking Univ, Beijing Int Ctr Math Res, Beijing 100191, Peoples R China
基金
中国国家自然科学基金; 比尔及梅琳达.盖茨基金会;
关键词
Delta variants; Omicron variants; B.1.617.2; AY.4; BA.1; reproductive number; vaccination; nonpharmaceutical interventions; COVID-19; DYNAMICS;
D O I
10.3390/vaccines10040496
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Omicron, the latest SARS-CoV-2 Variant of Concern (VOC), first appeared in Africa in November 2021. At present, the question of whether a new VOC will out-compete the currently predominant variant is important for governments seeking to determine if current surveillance strategies and responses are appropriate and reasonable. Based on both virus genomes and daily-confirmed cases, we compare the additive differences in growth rates and reproductive numbers (R-0) between VOCs and their predominant variants through a Bayesian framework and phylo-dynamics analysis. Faced with different variants, we evaluate the effects of current policies and vaccinations against VOCs and predominant variants. The model also predicts the date on which a VOC may become dominant based on simulation and real data in the early stage. The results suggest that the overall additive difference in growth rates of B.1.617.2 and predominant variants was 0.44 (95% confidence interval, 95% CI: -0.38, 1.25) in February 2021, and that the VOC had a relatively high R-0. The additive difference in the growth rate of BA.1 in the United Kingdom was 6.82 times the difference between Delta and Alpha, and the model successfully predicted the dominating process of Alpha, Delta and Omicron. Current vaccination strategies remain similarly effective against Delta compared to the previous variants. Our model proposes a reliable Bayesian framework to predict the spread trends of VOCs based on early-stage data, and evaluates the effects of public health policies, which may help us better prepare for the upcoming Omicron variant, which is now spreading at an unprecedented speed.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Performance of nasopharyngeal swab and saliva in detecting Delta and Omicron SARS-CoV-2 variants
    Ursic, Tina
    Kogoj, Rok
    Sikonja, Jaka
    Roskaric, Damijana
    Virant, Monika Jevsnik
    Bogovic, Petra
    Petrovec, Miroslav
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (10) : 4704 - 4711
  • [32] Secondary Attack Rates for Omicron and Delta Variants of SARS-CoV-2 in Norwegian Households
    Jorgensen, Silje B.
    Nygard, Karin
    Kacelnik, Oliver
    Telle, Kjetil
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 327 (16): : 1610 - 1611
  • [33] Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants
    Feng, Sheng
    Fan, Zechang
    Zhou, Keyue
    Ma, Shanshan
    Liang, Mingzheng
    Zhang, He
    Xie, Yubiao
    Ha, Zhuo
    Jin, Ningyi
    Lu, Huijun
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (10)
  • [34] A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters
    Zhao, Hanjun
    To, Kelvin Kai-Wang
    Lam, Hoiyan
    Zhang, Chuyuan
    Peng, Zheng
    Meng, Xinjie
    Wang, Xiankun
    Zhang, Anna Jinxia
    Yan, Bingpeng
    Cai, Jianpiao
    Yeung, Man Lung
    Chan, Jasper Fuk-Woo
    Yuen, Kwok-Yung
    CELL DISCOVERY, 2022, 8 (01)
  • [35] Serial Intervals and Incubation Periods of SARS-CoV-2 Omicron and Delta Variants, Singapore
    Zeng, Kangwei
    Santhya, Aijia
    Soong, Aijia
    Malhotra, Nitika
    Pushparajah, Dhanushanth
    Thoon, Koh Cheng
    Yeo, Benny
    Ho, Zheng Jie Marc
    I-Cheng, Mark Chen
    EMERGING INFECTIOUS DISEASES, 2023, 29 (04) : 814 - 817
  • [36] SARS-CoV-2 Vaccine Breakthrough Infections of Omicron and Delta Variants in Healthcare Workers
    Regenhardt, Elisa
    Kirsten, Holger
    Weiss, Melanie
    Luebbert, Christoph
    Stehr, Sebastian N.
    Remane, Yvonne
    Pietsch, Corinna
    Hoenemann, Mario
    von Braun, Amrei
    VACCINES, 2023, 11 (05)
  • [37] Airborne Transmission of the SARS-CoV-2 Delta Variant and the SARS-CoV-2 Omicron Variant
    Lee, Byung Uk
    AEROSOL AND AIR QUALITY RESEARCH, 2022, 22 (01)
  • [38] Omicron variants of SARS-CoV-2 and long COVID
    Yang, Chengliang
    Zhao, Hedi
    Shannon, Casey P.
    Tebbutt, Scott J.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [39] ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
    Ou, Jianxia
    Zhang, Yanan
    Wang, Yongmei
    Zhang, Zherui
    Wei, Hongping
    Yu, Junping
    Wang, Qi
    Wang, Guifeng
    Zhang, Bo
    Wang, Chunhe
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2022, 7 (01)
  • [40] ACE2-Targeting antibody suppresses SARS-CoV-2 Omicron and Delta variants
    Jianxia Ou
    Yanan Zhang
    Yongmei Wang
    Zherui Zhang
    Hongping Wei
    Junping Yu
    Qi Wang
    Guifeng Wang
    Bo Zhang
    Chunhe Wang
    Signal Transduction and Targeted Therapy, 7